Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Benza** is a prominent brand of over-the-counter (OTC) cold, cough, and rhinitis remedies developed and marketed by **Alinamin Pharmaceutical** (formerly Takeda Consumer Healthcare) in Japan. The Benza product line includes various specialized formulations tailored to target specific cold symptoms, such as sore throat, fever, runny nose, nasal congestion, and cough. These products are typically multi-ingredient fixed-dose combinations containing active pharmaceutical ingredients such as ibuprofen or acetaminophen (for pain and fever relief), pseudoephedrine hydrochloride (a nasal decongestant), d-chlorpheniramine maleate (an antihistamine), tranexamic acid (to reduce mucosal inflammation), and dihydrocodeine phosphate (a cough suppressant). Benza products are widely marketed in Japan in various dosage forms, including tablets, caplets, liquids, troches, and sprays, and are approved for the symptomatic relief of the common cold, allergic rhinitis, and sinusitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Benza.